ع
Current health expenditure in Bahrain is forecast to grow 6 percent a year to 2029, the slowest in the region after Oman. The cheapest capacity left is the kind women have been supplying unpaid for decades.
The Gulf is about to spend a great deal more on healthcare, and Bahrain is not where most of it lands. Alpen Capital’s GCC Healthcare Industry Report 2025 puts regional current health expenditure at $109.1 billion in 2024, rising to $159 billion by 2029 at a compound annual rate of 7.8 percent. Saudi Arabia grows fastest at 8.8 percent, Qatar at 8.3, the UAE at 6.7 and Kuwait at 6.3. Bahrain sits at 6.0, ahead only of Oman, and Saudi Arabia and the UAE will command 82.6 percent of regional spending by 2029.
A smaller budget growing more slowly does not reduce clinical demand. It changes what the answer has to look like.
The constraint is not the buildings
Bahrain is not under-supplied with facilities. NHRA reporting compiled in sector research counts 924 licensed healthcare facilities, 877 of them private, alongside 26 public primary health centres, on an island where no community is far from a clinic. Non-communicable diseases account for around 2,000 citizen deaths a year and life expectancy sits above 81.
That describes a chronic-care problem, not an acute-capacity one. Chronic disease is managed by attendance rather than admission, by the medication review that happens on time and the blood pressure checked in week six rather than month nine. The IDF Diabetes Atlas puts MENA’s age-standardised diabetes prevalence at the highest of any region in the world, with one in three adults living with diabetes undiagnosed and prevalence among older adults reaching 32.3 percent. World Bank figures put Bahrain’s population aged 65 and over at 61,218 in 2024. The system’s real leakage is the contacts that never happen.
Who absorbs the missed appointment
They do not vanish. When an elderly parent cannot get to a clinic, the appointment is not skipped so much as absorbed, usually by a daughter, a wife or a domestic worker who reorganises a day around it. The World Health Organization’s “Fair share for health and care” report sizes it: women make up 67 percent of the paid global health and care workforce and perform an estimated 76 percent of all unpaid care activities, while facing a pay gap of around 24 percent in the sector after controls.
None of that labour enters the national health accounts. Home-delivered clinical care is one of the few interventions that converts a slice of it into a licensed, paid, recorded transaction.
A founder who has been on both sides of the bed
Esbitar is built for exactly that segment. The Bahraini company runs a mobile medical clinic bringing licensed doctors and nurses to patients at home across the Kingdom, with the unit of service a visit rather than a bed. Its founder and chief executive, Dr Iman Shefi, is a general practitioner certified in clinical psychology who describes herself as an advocate for older-person medicine.
The origin of that position is on the record. In September 2022, Shefi had a stroke. Speaking to News of Bahrain’s TalkPoint, she described finding herself “the patient on one of our department emergency beds,” and said the shock came not from the diagnosis but from “the inability to move.” She names the ambition that followed in three words: “to humanize medicine.”
Founders who have been the patient in the system they are rebuilding are rarer in health services than the marketing implies, and it shows in what Esbitar optimises for. The company is not selling faster triage. It is selling the contact that would otherwise be missed.
The name, and the precedent
Sbitar was the word used across the Arabian Peninsula for hospital, borrowed from the English and reshaped, and it faded, as Okaz has noted, once mustashfa, mustawsaf and iyada arrived with the modern institutions. Reviving it for a clinic that travels is a deliberate inversion.
Nor is the model an import. Dr Abdulla Kamal Medical Centre, which opened on Shaikh Isa Avenue in 1974 and became Bahrain’s first 24-hour clinic, still lists home visits among its services half a century on. What is new is the regulatory frame. The NHRA licenses both the professionals and the facility, with no exemption for services delivered remotely from inside Bahrain, which places a mobile clinic inside regulated medicine rather than the wellness market and gives a payer something it can contract with.
The limit worth stating plainly
Here the argument concedes something real. In most markets where home care wins, it wins on distance, and Bahrain has almost none. A country this compact cannot make the geographic case that justifies home delivery in Saudi Arabia’s interior or rural Oman. It has to win on adherence, convenience and continuity, which are harder to price and which insurers have historically been reluctant to reimburse. A visiting clinician cannot do imaging, surgery or emergency care, and a fleet model risks fragmenting a record the primary health centres already hold. That is a genuine ceiling on how much of Bahrain’s 6 percent this segment can take.
But the alternative is not free. It is a cost that sits outside the health accounts entirely, carried by households, growing at the same rate as the patient cohort.
